COMPANY
Modulo Bio
NIH awards 4
- NIH award 1R44NS143633-01A1 FY2026: $847,695 awarded for that fiscal year; activity R44 (SBIR); PI LIM, RYAN GAR-LOK; recipient as written: MODULO BIO, INC., San Diego, CA. The Therapeutic Development of a Clinical N source ↗
- NIH award 1R61MH143793-01 FY2026: $1,479,470 awarded for that fiscal year; activity R61 (OTHER_NIH); PI SCHAFFERT, STEVEN A; recipient as written: MODULO BIO, INC., San Diego, CA. Developing an AI-Guided Triculture P source ↗
- NIH award 5R44MH135465-02 FY2024: $1,428,644 awarded for that fiscal year; activity R44 (SBIR); PI SACHS, KAREN; recipient as written: MODULO BIO, INC., San Diego, CA. Implementing a coupled system of integrative ML source ↗
- NIH award 1R44MH135465-01 FY2023: $1,457,344 awarded for that fiscal year; activity R44 (SBIR); PI SACHS, KAREN; recipient as written: MODULO BIO, INC., San Diego, CA. Implementing a coupled system of integrative ML source ↗
Funding and NIH signals
- NIH award NIH awarded $848K (SBIR Phase II 1R44NS143633-01A1, new, notice Sep 19, 2026); 2 NIH awards totaling $2.33M in the last 12 months. NIH RePORTER 1R44NS143633-01A1 (Sep 19, 2026)
Evidence (2 events)
- Sep 19, 2026 · NIH RePORTER 1R44NS143633-01A1
Organization: MODULO BIO, INC.; City/State: San Diego, CA; Project number: 1R44NS143633-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-19; FY total cost (award amount): 847695; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: The Therapeutic Development of a Clinical NR1H3 Antisense Oligonucleotide to Reprogram Microglia into a Neuroprotective State in ALS and FTD; Organization type: Domestic For-Profits - Feb 25, 2026 · NIH RePORTER 1R61MH143793-01
Organization: MODULO BIO, INC.; City/State: San Diego, CA; Project number: 1R61MH143793-01; Activity code: R61; Fiscal year: 2026; Award notice date: 2026-02-25; FY total cost (award amount): 1479470; Administering IC: National Institute of Mental Health; Project title: Developing an AI-Guided Triculture Platform to Model NeuroHIV specific Microglial States Under ART Suppression with CellPaint/Morphological and Transcriptomic Readouts; Organization type: Domestic For-Profits
- Sep 19, 2026 · NIH RePORTER 1R44NS143633-01A1